On 5 September 2025, the European Commission published the Draft Adequacy Decision recognizing Brazil as a country that ensures an adequate level of protection for personal data, pursuant to Article 45 of the General Data Protection Regulation (GDPR). This proposal marks the beginning of the formal procedure to authorize the transfer of personal data from the European Union to Brazil without the need for additional safeguards, effectively treating such transfers as equivalent to those occurring within the EU.

The week of July 14 to 18, 2025 marked a historic moment for the U.S. cryptocurrency industry, as the U.S. House of Representatives officially designated it “Crypto Week”. This initiative signalled a profound shift in how Washington approaches the burgeoning digital asset landscape, moving from cautious observation to active legislative engagement. While much of the attention landed on the GENIUS Act, it is also important to understand the implications of the CLARITY Act and the Anti-CBDC Act.

On 13 August 2025, Mexico’s Ministry of Economy launched an anti-dumping investigation into adult bicycle imports from China, citing price discrimination from 2022–2024. Five Mexican companies filed the petition, and 261 importers/exporters are named. The probe may lead to countervailing duties if injury to domestic producers is confirmed. Interested parties must submit evidence by 23 September 2025, with possible extensions.

On 15 August 2025, Singapore’s Health Sciences Authority (HSA) issued an update listing overseas health products found to contain potent, prohibited ingredients. These may cause harmful side effects. The HSA advises consumers to avoid such products and buy only from trusted sources. Sellers in Singapore face severe penalties for supplying adulterated products. The HSA continues monitoring global enforcement to protect local consumers and urges suppliers to assess any overseas regulatory impacts.